Drugs / MV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02338778 | Jan → Aug 2015 | liver and intrahepatic bile duct neoplasm | Fuda Cancer Hospital, Guangzhou | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02338778 ↗ |
| Route | Subcutaneous | “MV is an intravenous intralipid suspension” NCT02338778 ↗ |